Hydrochlorothiazide / Olmesartan
Also known as: Benicar Hct, Benicar Hydrochlorothiazide, Olmesartan-Hydrochlorothiazide.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 20-12.5 MG | Tablet | $0.182 / unit | Generic |
| 40-12.5 MG | Tablet | $0.238 / unit | Generic |
| 40-25 MG | Tablet | $0.232 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $2,134,765 gross for Hydrochlorothiazide / Olmesartan across 87,072 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$34,971,448 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS